Financials
Financial year 2023
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
Gross margin
€ -41,839
▲ 76% vs 2022
Profit
Caution€ -44,940
▲ 82% vs 2022
Debts
High€ 2.3 million
▲ 3% vs 2022
PROTEA BIOPHARMA NV from Asse, company number BE0820421545, closed financial year 2023 with a result of € -44,940 after tax. For that financial year PROTEA BIOPHARMA NV recorded a gross margin of € -41,839 and equity of € -999,054. Compared with financial year 2022, the result moved from € -244,094 to € -44,940. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2024.
What happened at PROTEA BIOPHARMA NV?
What happened at PROTEA BIOPHARMA NV in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jean-Paul Deslypere stepped down as director. NBB
- Carine Herbots stepped down as director. NBB
- New annual accounts for financial year 2023: loss of € 44,940. filed late Source: NBB ↗
- Jan Cabri stepped down as director. NBB
- Carine Herbots became a director. NBB
- Jean-Paul Deslypere became a director. NBB
- Jan Cabri became a director. NBB
- New establishment in Brussel. KBO
In short
From € 142,885 loss in 2021 to € 44,940 loss in 2023.
A new publication or filing at PROTEA BIOPHARMA NV? We notify you, reason included.
Follow PROTEA BIOPHARMA NVNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of KALIDA BV itself.
Directors
According to the 2023 annual accounts
Carine Herbots
Director
since 2024 · until 2025
Jan Cabri
Director
since 2021 · until 2024
since 2022 · until 2028
Establishments
Establishment units
Physical locations of this company
Huinegem 42 box B
1730 Asse
de Tyraslaan 111
1120 Brussel
Active since 10 November 2009
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
Details
- Company number
- 0820.421.545
- VAT number
- BE 0820.421.545
- Registered office
- Huinegem 42 bus B, 1730 Asse
- Names & denominations
- PROTEA BIOPHARMA NV
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 10 November 2009
- Peppol
- Active · Active since 30 Dec 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten